Medicare Enrolled

Dr. Chandan Cheema, MD

Geriatric Medicine (Internal Medicine) Physician · Yuba City, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1215 PLUMAS ST STE 1300B, Yuba City, CA 95991
5307631900
In practice since 2006 (19 years)
NPI: 1053488114 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheema from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheema? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheema

Dr. Chandan Cheema is a geriatric medicine physician in Yuba City, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cheema performed 19,856 Medicare services across 811 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheema received a total of $112 from 5 pharmaceutical and/or device companies across 5 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheema is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in CA $112 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,856
Medicare services
Top 2% in CA for geriatric medicine (internal medicine) physician
811
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,045 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
9,425 $34 $66
Injection, tildrakizumab, 1 mg 4,600 $110 $228
Denosumab injection (Prolia/Xgeva) 3,660 $18 $37
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
572 $1 $32
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
540 $55 $149
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
176 $12 $36
Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 168 $61 $160
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
155 $47 $150
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
139 $111 $300
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
86 $24 $77
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
85 $6 $16
Nursing facility visit, established patient, straightforward
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes.
56 $23 $120
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
53 $72 $170
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
40 $102 $206
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
35 $13 $71
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $45 $178
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $68 $182
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
22 $1 $33
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.9% high complexity
43.5% medium
2.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$112
Total received (2020-2024)
Avg $28/year across 4 years
Bottom 35% in CA for geriatric medicine (internal medicine) physician
5
Companies
5
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$112 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$52
2023
$19
2022
$23
2020
$19

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$27
Genentech USA, Inc.
$25
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2020-2024) ›
Lilly USA, LLC
$27
Genentech USA, Inc.
$25
Melinta Therapeutics, LLC
$23
Collegium Pharmaceutical, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Top 3 companies account for 66.0% of all-time payments
Associated products mentioned in payments ›
Belbuca · INVOKANA · Ocrevus Zunovo · Orbactiv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a geriatric medicine physician in Yuba City?
Compare geriatric medicine physicians in the Yuba City area by procedure volume, costs, and industry payment transparency.
Browse geriatric medicine physicians nearby

Geographic Context

Geriatric medicine physicians within 10 mi
2
Per 100K population
2.0
County median income
$75,450
Nearest hospital
SUTTER SURGICAL HOSPITAL - NORTH VALLEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cheema is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cheema experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Cheema performed 9,425 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheema receive payments from pharmaceutical companies?
Yes. Dr. Cheema received a total of $112 from 5 companies across 5 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheema's costs compare to other geriatric medicine physicians in Yuba City?
Dr. Cheema's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheema) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →